Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Postgraduate Medicine|October 12, 2013
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 studyAllan Gibofsky, Stephen Silberstein, Charles Argoff, et al.
Rheumatology International|August 31, 2017
Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature reviewChak Sing Lau, Allan Gibofsky, Nemanja Damjanov, et al.
Current Medical Research and Opinion|September 6, 2017
Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitorsAllan Gibofsky, Martha Skup, Manish Mittal, et al.
Journal of Managed Care & Specialty Pharmacy|March 29, 2023
An online survey among US patients with immune-mediated conditions: Attitudes about biosimilarsAllan Gibofsky, Gary Jacobson, Archie Franklin, et al.
Clinical and Experimental Rheumatology|March 5, 2015
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)Allan Gibofsky, Grant W Cannon, David J Harrison, et al.
The Journal of Rheumatology|May 17, 2011
Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registryJoseph A Markenson, Allan Gibofsky, William R Palmer, et al.
Annals of the Rheumatic Diseases|February 2, 2012
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registryJeffrey D Greenberg, George Reed, Dennis Decktor, et al.
Seminars in Arthritis and Rheumatism|September 10, 2020
Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologistsBella Mehta, Deanna Jannat-Khah, Carol A Mancuso, et al.
The Journal of Rheumatology|October 19, 2010
Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registriesAllan Gibofsky, William R Palmer, Edward C Keystone, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 23, 2020
Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among RheumatologistsBella Mehta, Carine J Moezinia, Deanna Jannat-Khah, et al.
Pageof 6